Expanding Virtual Care to Uro-Oncology.

Kranus Health is providing a full range of therapies from Andrology to Uro-Oncology, actively broadening its array of virtual care journeys backed by clinical evidence.

Treatment landscape for Prostate Cancer has dramatically expanded.

Patients need better support during their oncology treatment with:

  • Psychological distress​​

  • Physical impairment​

  • Cognitive impairment​

  • Disease symptoms​

  • Tracking and treatment of side-effects 

  • Patient education​

Our Approach: Evidence-Based Science developed with a diverse Medical Advisory Board.

  • Prof. Laura Maria Krabbe​

    Medical Advisor

    Chief Physician of Urology at Vivantes Humboldt Hospital since 2023

  • Prof. Dr. Oliver Grimm​

    Medical Advisor

    Director of the Clinic for Urology, University Hospital Jena, Chairman of the Steering Committee for the S3 Guideline on Prostate Cancer

  • Prof. Dr. Mehnert-Theuerkauf

    Medical Advisor

    Chair in Medical Psychology and Medical Sociology, University Medical Center Leipzig

  • Prof. Dr. Maria De Santis

    Medical Advisor

    Head of the Department of Interdisciplinary Urological Oncology at Charité

  • Prof. Dr. Freerk Baumann 

    Medical Advisor

    Leader Studygroup Oncological Exercise University of Cologne (UOC)

  • Dr. Laura Wiemer

    Senior Medical Director

    Practicing urologist with additional qualifications in medical tumor therapy and former Charite doctor in urology and andrology

  • Prof. Dr. Kurt Miller

    Chief Medical Officer

    Former Medical Director of the Department of Urology at the Charité in Berlin

  • Prof. Dr. Ehsan Khaljani

    Senior Advisor

    Urologist and Head of the Digital Health Management program at Medical School Berlin

  • Dr. Eva Hellmis

    Medical Advisor

    Specialist in urology with additional qualifications in medical tumor therapy, andrology, and palliative medicine

Get more information

Transforming Prostate Cancer Care.

The multimodal therapy for self-treatment includes:

  • Symptom and Side-effect Management

  • Psycho-oncology Intervention

  • Cardiovascular & ​Resistance Training​

  • Meditation & Cognitive Exercises

  • Knowledge Section​ including nutrition tips

Creating a Holistic Therapy View.

Symptom and side-effect tracking combined with wearable data, PROMs, PSA Tracking and adherence to medications will provide a holostic therapy view.

Symptom tracking

PROMs

PSA

Medication adherence

Wearable data

Partner up?

Are you a pharmaceutical company seeking further information?

Empowering Doctors: Streamlined Care, Enhanced Monitoring.

  • Reduced patient education time

  • Enhanced therapy monitoring capabilities

  • Practical information for patients to reference after the initial shock

  • Improved side effect management

  • Patients seek medical assistance only when necessary

Development is fully under way, the product will be completed this year.

Next step: Start of clinical trial A prospective randomized study on multimodal self-treatment of men with prostate cancer under drug therapy.

Diagnoses:

Men with prostate cancer undergoing drug therapy (ADT and combination therapies) 

ICD-10 code: 

C61